Sang-Won Park Selected Research

Fever (Fevers)

3/2016	Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease.
12/2012	Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang-Won Park Research Topics

Disease

11	Infections 01/2021 - 02/2009
10	COVID-19 01/2024 - 08/2020
7	Stroke (Strokes) 07/2022 - 01/2017
5	Sepsis (Septicemia) 09/2020 - 09/2003
5	Bacteremia 10/2012 - 09/2003
4	Inflammation (Inflammations) 10/2022 - 01/2008
3	Cognitive Dysfunction 10/2023 - 05/2018
3	Neoplasms (Cancer) 08/2022 - 07/2003
3	Dementia (Dementias) 06/2022 - 01/2017
3	Neutropenia 12/2012 - 01/2010
2	Ischemic Stroke 10/2023 - 01/2022
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 11/2020
2	Neuroinflammatory Diseases 10/2022 - 07/2022
2	Diabetes Mellitus 08/2022 - 11/2011
2	Hypersensitivity (Allergy) 07/2022 - 02/2009
2	Severe Acute Respiratory Syndrome 06/2022 - 03/2022
2	Pneumonia (Pneumonitis) 03/2022 - 09/2003
2	Fever (Fevers) 03/2016 - 12/2012
2	Human Influenza (Influenza) 06/2013 - 02/2011
2	Hepatocellular Carcinoma (Hepatoma) 06/2008 - 07/2003
1	Conversion Disorder (Astasia Abasia) 09/2023
1	Obesity 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Metabolic Brain Diseases (Encephalopathy, Metabolic) 07/2022
1	Insulin Resistance 07/2022
1	Atherosclerosis 07/2022
1	Hypoxia (Hypoxemia) 07/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Lymphopenia (Lymphocytopenia) 07/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2022
1	Chronic Renal Insufficiency 03/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2022

Drug/Important Bio-Agent (IBA)

6	Oxygen (Dioxygen)IBA 09/2023 - 03/2022
5	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
5	Escitalopram FDA Link 11/2021 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2022 - 03/2012
4	C-Reactive ProteinIBA 04/2022 - 11/2011
3	Monoclonal AntibodiesIBA 06/2022 - 10/2011
3	CytokinesIBA 04/2022 - 03/2002
2	remdesivirIBA 01/2024 - 07/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 12/2007
2	nirmatrelvir and ritonavir drug combinationIBA 09/2023 - 02/2023
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
2	Antidepressive Agents (Antidepressants)IBA 10/2022 - 11/2021
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2022 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2022 - 07/2022
2	CholesterolIBA 07/2022 - 11/2019
2	regdanvimabIBA 06/2022 - 03/2022
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2022 - 01/2017
2	Serotonin (5 Hydroxytryptamine)IBA 11/2021 - 01/2018
2	beta-Lactamases (beta-Lactamase)IBA 09/2020 - 04/2009
2	AntigensIBA 11/2015 - 05/2015
2	titanium nitride (titanium nitride (TiN))IBA 04/2015 - 10/2012
2	Methicillin (Metin)FDA Link 06/2013 - 11/2011
2	OsteopontinIBA 11/2011 - 06/2008
1	Antiviral Agents (Antivirals)IBA 01/2024
1	Messenger RNA (mRNA)IBA 10/2023
1	AminesIBA 09/2023
1	Carbon MonoxideIBA 09/2023
1	phosphatidylethanolamineIBA 01/2023
1	CalciumIBA 01/2023
1	SolutionsIBA 01/2023
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Biogenic Amines (Biogenic Amine)IBA 01/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	Ointments (Pastes)IBA 01/2023
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2023
1	Monoamine Oxidase (MAO)IBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	bafilomycin A1IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	TyramineIBA 01/2023
1	SaltsIBA 01/2023
1	Glutamic Acid (Glutamate)FDA Link 10/2022
1	N-Methylaspartate (NMDA)IBA 10/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2022
1	oxidized low density lipoproteinIBA 07/2022
1	Apolipoproteins E (ApoE)IBA 07/2022
1	ApolipoproteinsIBA 07/2022
1	Amyloid beta-PeptidesIBA 07/2022
1	LDL Receptors (LDL Receptor)IBA 07/2022
1	SteroidsIBA 07/2022
1	GlucocorticoidsIBA 07/2022
1	Phosphodiesterase 5 InhibitorsIBA 06/2022
1	Interleukin-1 (Interleukin 1)IBA 04/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022
1	Protein Kinases (Protein Kinase)IBA 02/2022
1	Claudin-5IBA 02/2022
1	Donepezil (Aricept)FDA LinkGeneric 01/2022

Therapy/Procedure

10	Therapeutics 09/2023 - 09/2003
3	Critical Care (Surgical Intensive Care) 01/2017 - 01/2010
2	Catheters 09/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 03/2016 - 12/2012
1	Personal Protective Equipment 04/2022
1	Thrombectomy 01/2022